Shares in Novo Nordisk, the Danish firm best known for its Wegovy and Ozempic weight loss drugs, have plunged after
Ozempic-maker’s shares plunge after failed Alzheimer’s trial
Investors take the value of the company’s shares back to where they stood in July 2021 following Novo Nordisk’s announcement.
